Advice
Following an abbreviated submission
Mesalazine 800 mg modified release tablet (Asacol) is accepted for use in NHS Scotland for the treatment of mild acute exacerbations of ulcerative colitis.
At the recommended dose of up to 2.4g daily, the 800 mg strength allows halving of the pill burden compared with the 400 mg formulation at no extra cost.
Download detailed advice53KB (PDF)
Medicine details
- Medicine name:
- mesalazine (Asacol)
- SMC ID:
- 223/05
- Indication:
- Mild acute exacerbations for ulcerative colitis
- Pharmaceutical company
- Procter and Gamble
- BNF chapter
- Gastro-intestinal system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 11 February 2008